- Investing Ideas
- Australian Pharmaceuticals & Biotech Profitable Climbers
Australian Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Clinuvel Pharmaceuticals
Market Cap: AU$546.2m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.72
7D
-8.6%
1Y
-4.7%
Medical Developments International
Market Cap: AU$51.8m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.47
7D
3.3%
1Y
-45.4%
Telix Pharmaceuticals
Market Cap: AU$3.3b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$9.08
7D
-10.4%
1Y
-66.5%